World's largest Alzheimer's survey reveals most adults believe a cure will be developed in their lifetime

Novartis International AG / World's largest Alzheimer's survey reveals most adults believe a cure will be developed in their lifetime . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

• From a sample of over 10,000 adults, 62% are worried that they may develop Alzheimer's disease and 91% believe the solution to tackling diseases lies in medical research[1]
   

79% are willing to take part in medical research but three-quarters (75%) have no idea how to get involved[1]
 

This World Alzheimer's Month, in association with Alzheimer's Disease International, Novartis, Amgen and Banner Alzheimer's Institute are raising awareness about how to get involved in Alzheimer's research

The digital press release with multimedia content can be accessed here:

Basel, September 17, 2018 - Novartis, Amgen and Banner Alzheimer's Institute (BAI), in association with Alzheimer's Disease International (ADI), today announced results from the largest global survey to date investigating perceptions of Alzheimer's disease. Findings show that most adults (62%) are worried that they may develop Alzheimer's, while nearly the same proportion believe it is likely a cure will be developed in their lifetime (60%).[1] This World Alzheimer's Month, Novartis, Amgen, BAI and ADI are raising awareness about how volunteers can take part in clinical studies to benefit Alzheimer's research, potentially themselves and future generations.

Alzheimer's is the leading cause of dementia, a disease affecting 50 million people worldwide and this number is expected to triple by 2050.[2] The survey of more than 10,000 people across 10 countries revealed that 91% believe the solution to tackling diseases lies in medical research and 79% are willing to participate.[1] However, three-quarters (75%) have no idea how to get involved in medical research.[1] In addition, 78% of adults are willing to get genetically tested to identify their potential risk of developing Alzheimer's.[1]